TD Waterhouse Canada’s Caribou Biosciences CRBU Stock Holding History

TD Waterhouse Canada’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.98K	Hold	1,000	–	–	﹤0.01%	2041
2025 Q4	$1.58K	Hold	1,000	–	–	﹤0.01%	1847
2025 Q3	$2.27K	Sell	1,000 -30	-3%	-$57	﹤0.01%	1811
2025 Q2	$1.29K	Hold	1,030	–	–	﹤0.01%	1782
2025 Q1	$866	Hold	1,030	–	–	﹤0.01%	1757
2024 Q4	$1.64K	Hold	1,030	–	–	﹤0.01%	1727
2024 Q3	$1.89K	Hold	1,030	–	–	﹤0.01%	1637
2024 Q2	$1.64K	Hold	1,030	–	–	﹤0.01%	1668
2024 Q1	$4.91K	Hold	1,030	–	–	﹤0.01%	1540
2023 Q4	$7.04K	Buy	1,030 +1,000	+3,333%	+$4.94K	﹤0.01%	1320
2023 Q3	$136	Hold	30	–	–	﹤0.01%	1654
2023 Q2	$128	Hold	30	–	–	﹤0.01%	1696
2023 Q1	$164	Hold	30	–	–	﹤0.01%	1688
2022 Q4	$198	Hold	30	–	–	﹤0.01%	1648
2022 Q3	$317	Hold	30	–	–	﹤0.01%	1643
2022 Q2	$160	Hold	30	–	–	﹤0.01%	1705
2022 Q1	$277	Hold	30	–	–	﹤0.01%	1729
2021 Q4	$433	Buy	+30	New	+$583	﹤0.01%	1690

Other funds holding CRBU

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TD Waterhouse Canada's CRBU Position: Q1 2026 in Review

TD Waterhouse Canada held its Caribou Biosciences (CRBU) position steady in Q1 2026 at 1,000 shares worth $1.98K. The position accounts for ﹤0.01% of the portfolio, ranked #2041.

TD Waterhouse Canada first reported a position in CRBU in Q4 2021 and has held it in 18 quarters since. The position peaked at $7.04K in Q4 2023. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

TD Waterhouse Canada held 1,000 shares of Caribou Biosciences worth $1.98K as of Q1 2026.
TD Waterhouse Canada left its Caribou Biosciences share count unchanged in Q1 2026.
Caribou Biosciences made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q1 2026, its #2041 holding.
TD Waterhouse Canada first reported a position in Caribou Biosciences in Q4 2021 and has held it in 18 quarters since.
TD Waterhouse Canada's Caribou Biosciences position peaked at $7.04K in Q4 2023.
137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.